Gene · 2046
Papers2,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gonadotropin-Releasing Hormone Receptor (GnRHR) and Hypogonadotropic Hypogonadism. | Int J Mol Sci | 2023 | 37958948 | PubTator, text mining | PubMed |
| Protein Tyrosine Phosphatase CD45 As an Immunity Regulator and a Potential Effector of CAR-T therapy. | Acta Naturae | 2023 | 37908772 | PubTator, text mining | PubMed |
| Role of RNA Alternative Splicing in T Cell Function and Disease. | Genes (Basel) | 2023 | 37895245 | PubTator, text mining | PubMed |
| Role of Non-Coding RNAs in TGF-β Signalling in Glioma. | Brain Sci | 2023 | 37891744 | PubTator, text mining | PubMed |
| The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies. | Cancer Cell Int | 2023 | 37891636 | PubTator, text mining | PubMed |
| Network pharmacology-based strategy to investigate the effect and mechanism of α-solanine against glioma. | BMC Complement Med Ther | 2023 | 37865727 | PubTator, text mining | PubMed |
| Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms. | Front Endocrinol (Lausanne) | 2023 | 37859992 | PubTator, text mining | PubMed |
| mRNA trans-splicing dual AAV vectors for (epi)genome editing and gene therapy. | Nat Commun | 2023 | 37852949 | PubTator, text mining | PubMed |
| B Cell Tolerance and Targeted Therapies in SLE. | J Clin Med | 2023 | 37834911 | PubTator, text mining | PubMed |
| Characterization of the lncRNA-mediated ceRNA regulatory networks in preeclampsia by integrated bioinformatics. | Sci Rep | 2023 | 37828060 | PubTator, text mining | PubMed |
| Extracellular vesicles in hematological malignancies: EV-dence for reshaping the tumoral microenvironment. | Front Immunol | 2023 | 37822925 | PubTator, text mining | PubMed |
| Clinical features and mutational analysis of X-linked agammaglobulinemia patients in Malaysia. | Front Immunol | 2023 | 37809070 | PubTator, text mining | PubMed |
| P21-activated kinase 1 (PAK1)-mediated cytoskeleton rearrangement promotes SARS-CoV-2 entry and ACE2 autophagic degradation. | Signal Transduct Target Ther | 2023 | 37806990 | PubTator, text mining | PubMed |
| Targeting NHE6 gene expression identifies lysosome and neurodevelopmental mechanisms in a haploid in vitro cell model. | Biol Open | 2023 | 37747131 | PubTator, text mining | PubMed |
| Network pharmacology combined with molecular docking and in vitro verification reveals the therapeutic potential of Delphinium roylei munz constituents on breast carcinoma. | Front Pharmacol | 2023 | 37724182 | PubTator, text mining | PubMed |
| Micro-simulation insights into the functional and mechanistic understanding of glycyrrhizin against asthma. | Front Pharmacol | 2023 | 37711178 | PubTator, text mining | PubMed |
| Quercetin inhibits the metabolism of arachidonic acid by inhibiting the activity of CYP3A4, thereby inhibiting the progression of breast cancer. | Mol Med | 2023 | 37710176 | PubTator, text mining | PubMed |
| Recent advances in JAK inhibitors for the treatment of metabolic syndrome. | Front Pharmacol | 2023 | 37701031 | PubTator, text mining | PubMed |
| Multi-Anticancer Activities of Phytoestrogens in Human Osteosarcoma. | Int J Mol Sci | 2023 | 37686148 | PubTator, text mining | PubMed |
| Pluripotential GluN1 (NMDA NR1): Functional Significance in Cellular Nuclei in Pain/Nociception. | Int J Mol Sci | 2023 | 37686003 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2046/papers?page=5